 Jason Stumhofer
Concepts (173)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Malaria | 11 | 2022 | 37 | 5.040 |
Why?
| | Plasmodium yoelii | 8 | 2023 | 14 | 3.530 |
Why?
| | T-Lymphocytes, Helper-Inducer | 8 | 2022 | 42 | 2.540 |
Why?
| | Spleen | 4 | 2022 | 170 | 1.920 |
Why?
| | Antibodies, Protozoan | 4 | 2018 | 12 | 1.760 |
Why?
| | B-Lymphocytes | 6 | 2025 | 175 | 1.690 |
Why?
| | Inducible T-Cell Co-Stimulator Protein | 3 | 2022 | 3 | 1.430 |
Why?
| | Interleukin-17 | 8 | 2017 | 37 | 1.390 |
Why?
| | Interleukin-10 | 5 | 2023 | 83 | 1.370 |
Why?
| | Immunologic Memory | 4 | 2022 | 29 | 1.270 |
Why?
| | Interleukins | 8 | 2014 | 32 | 1.260 |
Why?
| | Cytokines | 7 | 2023 | 606 | 1.160 |
Why?
| | Mice, Inbred C57BL | 18 | 2025 | 1773 | 1.050 |
Why?
| | Germinal Center | 5 | 2025 | 28 | 0.940 |
Why?
| | Mice | 23 | 2025 | 5633 | 0.940 |
Why?
| | Animals | 28 | 2025 | 13044 | 0.850 |
Why?
| | Mice, Knockout | 14 | 2025 | 832 | 0.830 |
Why?
| | CD4-Positive T-Lymphocytes | 5 | 2018 | 155 | 0.790 |
Why?
| | Immunity | 1 | 2021 | 34 | 0.730 |
Why?
| | T-Lymphocytes | 3 | 2013 | 328 | 0.690 |
Why?
| | Lymphocyte Activation | 3 | 2020 | 171 | 0.690 |
Why?
| | Cell Differentiation | 11 | 2025 | 651 | 0.680 |
Why?
| | Interleukin-12 | 2 | 2019 | 29 | 0.670 |
Why?
| | Multigene Family | 1 | 2019 | 56 | 0.660 |
Why?
| | NK Cell Lectin-Like Receptor Subfamily B | 1 | 2018 | 3 | 0.640 |
Why?
| | Antigens, Ly | 1 | 2018 | 11 | 0.640 |
Why?
| | T-Lymphocyte Subsets | 2 | 2015 | 38 | 0.590 |
Why?
| | Antibody-Producing Cells | 1 | 2017 | 3 | 0.590 |
Why?
| | Lymphoid Progenitor Cells | 1 | 2017 | 2 | 0.590 |
Why?
| | Toxoplasma | 4 | 2013 | 39 | 0.550 |
Why?
| | Precursor Cells, B-Lymphoid | 1 | 2016 | 7 | 0.550 |
Why?
| | Signal Transduction | 6 | 2020 | 1602 | 0.540 |
Why?
| | Th1 Cells | 6 | 2018 | 53 | 0.530 |
Why?
| | Toxoplasmosis | 3 | 2013 | 15 | 0.520 |
Why?
| | Cytokine Receptor gp130 | 2 | 2011 | 12 | 0.470 |
Why?
| | Interleukin-6 | 3 | 2011 | 265 | 0.430 |
Why?
| | Interferon-gamma | 5 | 2023 | 176 | 0.380 |
Why?
| | Cell Proliferation | 4 | 2025 | 985 | 0.370 |
Why?
| | Erythrocytes | 3 | 2022 | 83 | 0.360 |
Why?
| | Flow Cytometry | 6 | 2016 | 471 | 0.340 |
Why?
| | Mice, Inbred BALB C | 3 | 2018 | 296 | 0.310 |
Why?
| | Immunity, Humoral | 2 | 2020 | 22 | 0.310 |
Why?
| | T-Lymphocytes, Regulatory | 2 | 2023 | 82 | 0.310 |
Why?
| | Plasmodium chabaudi | 2 | 2020 | 3 | 0.310 |
Why?
| | STAT1 Transcription Factor | 1 | 2007 | 25 | 0.300 |
Why?
| | STAT3 Transcription Factor | 1 | 2007 | 81 | 0.290 |
Why?
| | Protein Subunits | 3 | 2019 | 78 | 0.280 |
Why?
| | Receptors, Cytokine | 5 | 2014 | 11 | 0.260 |
Why?
| | Virus Latency | 1 | 2025 | 51 | 0.240 |
Why?
| | Herpesviridae Infections | 1 | 2025 | 53 | 0.240 |
Why?
| | Homeodomain Proteins | 2 | 2023 | 79 | 0.240 |
Why?
| | Cells, Cultured | 8 | 2017 | 1572 | 0.230 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2015 | 233 | 0.230 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2023 | 40 | 0.220 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2025 | 213 | 0.210 |
Why?
| | Cytidine Deaminase | 1 | 2022 | 12 | 0.200 |
Why?
| | Interleukin-2 | 5 | 2011 | 70 | 0.200 |
Why?
| | Immunoglobulin M | 1 | 2022 | 58 | 0.200 |
Why?
| | Immunoglobulin G | 1 | 2022 | 184 | 0.190 |
Why?
| | Plasmodium | 1 | 2021 | 3 | 0.190 |
Why?
| | Hematopoiesis | 1 | 2021 | 70 | 0.180 |
Why?
| | Adoptive Transfer | 1 | 2020 | 30 | 0.180 |
Why?
| | Growth Inhibitors | 2 | 2011 | 27 | 0.180 |
Why?
| | Lymphopoiesis | 1 | 2019 | 2 | 0.170 |
Why?
| | Lymphocyte Subsets | 1 | 2019 | 13 | 0.170 |
Why?
| | Male | 8 | 2020 | 25382 | 0.160 |
Why?
| | Immunity, Cellular | 1 | 2019 | 69 | 0.160 |
Why?
| | Malaria Vaccines | 1 | 2018 | 2 | 0.160 |
Why?
| | Melanoma | 1 | 2022 | 281 | 0.160 |
Why?
| | Parasitemia | 2 | 2016 | 8 | 0.160 |
Why?
| | Neoplasms, Experimental | 1 | 2019 | 111 | 0.160 |
Why?
| | Autoimmune Diseases | 1 | 2019 | 80 | 0.150 |
Why?
| | Structure-Activity Relationship | 1 | 2019 | 394 | 0.150 |
Why?
| | Immunity, Innate | 3 | 2014 | 104 | 0.150 |
Why?
| | Proto-Oncogene Proteins pp60(c-src) | 1 | 2017 | 5 | 0.150 |
Why?
| | Receptors, Interleukin-17 | 1 | 2017 | 2 | 0.150 |
Why?
| | STAT Transcription Factors | 2 | 2008 | 8 | 0.150 |
Why?
| | Chemokine CXCL12 | 1 | 2017 | 30 | 0.140 |
Why?
| | Inflammation | 2 | 2019 | 600 | 0.140 |
Why?
| | Mice, Transgenic | 4 | 2011 | 541 | 0.140 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2016 | 33 | 0.130 |
Why?
| | Hemeproteins | 1 | 2016 | 8 | 0.130 |
Why?
| | Gene Expression | 1 | 2018 | 611 | 0.130 |
Why?
| | Fluorescent Antibody Technique | 1 | 2015 | 112 | 0.130 |
Why?
| | Photoacoustic Techniques | 1 | 2016 | 71 | 0.120 |
Why?
| | Humans | 8 | 2021 | 49820 | 0.120 |
Why?
| | Orthomyxoviridae Infections | 1 | 2014 | 3 | 0.120 |
Why?
| | Influenza A virus | 1 | 2014 | 17 | 0.120 |
Why?
| | Minor Histocompatibility Antigens | 2 | 2011 | 17 | 0.120 |
Why?
| | Receptors, Interleukin-21 | 1 | 2013 | 1 | 0.110 |
Why?
| | Respiratory Tract Infections | 1 | 2014 | 76 | 0.110 |
Why?
| | Species Specificity | 1 | 2013 | 191 | 0.110 |
Why?
| | Encephalitis | 1 | 2013 | 40 | 0.100 |
Why?
| | Cell Survival | 1 | 2013 | 588 | 0.090 |
Why?
| | Cats | 1 | 2011 | 79 | 0.090 |
Why?
| | Tumor Necrosis Factor Ligand Superfamily Member 15 | 1 | 2010 | 1 | 0.090 |
Why?
| | Cyclosporine | 1 | 2011 | 65 | 0.090 |
Why?
| | Gene Expression Regulation | 2 | 2013 | 965 | 0.090 |
Why?
| | Antibody Formation | 1 | 2010 | 51 | 0.090 |
Why?
| | Disease Models, Animal | 1 | 2015 | 1404 | 0.090 |
Why?
| | Inflammation Mediators | 1 | 2011 | 110 | 0.090 |
Why?
| | Chronic Disease | 1 | 2013 | 563 | 0.090 |
Why?
| | Cell Separation | 1 | 2010 | 89 | 0.090 |
Why?
| | Th17 Cells | 1 | 2010 | 25 | 0.090 |
Why?
| | Lymphocytes | 1 | 2011 | 154 | 0.090 |
Why?
| | Toxoplasmosis, Animal | 1 | 2010 | 2 | 0.090 |
Why?
| | Antigens, CD | 1 | 2011 | 215 | 0.090 |
Why?
| | Leishmania major | 1 | 2009 | 8 | 0.080 |
Why?
| | Leishmaniasis, Cutaneous | 1 | 2009 | 13 | 0.080 |
Why?
| | Receptors, Thyroid Hormone | 1 | 2009 | 2 | 0.080 |
Why?
| | Immunosuppressive Agents | 1 | 2011 | 221 | 0.080 |
Why?
| | Receptors, Retinoic Acid | 1 | 2009 | 22 | 0.080 |
Why?
| | Killer Cells, Natural | 1 | 2010 | 107 | 0.080 |
Why?
| | Cell Lineage | 1 | 2009 | 83 | 0.080 |
Why?
| | Dexamethasone | 1 | 2011 | 424 | 0.080 |
Why?
| | Female | 6 | 2017 | 26509 | 0.080 |
Why?
| | Interleukin-23 | 1 | 2008 | 9 | 0.080 |
Why?
| | Receptors, Interleukin | 3 | 2014 | 10 | 0.070 |
Why?
| | Immunohistochemistry | 1 | 2010 | 971 | 0.070 |
Why?
| | Viral Matrix Proteins | 1 | 2025 | 10 | 0.060 |
Why?
| | Brain | 1 | 2013 | 1313 | 0.060 |
Why?
| | Herpesvirus 4, Human | 1 | 2025 | 39 | 0.060 |
Why?
| | Gammaherpesvirinae | 1 | 2025 | 26 | 0.060 |
Why?
| | Rhadinovirus | 1 | 2025 | 21 | 0.060 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2025 | 53 | 0.060 |
Why?
| | src-Family Kinases | 1 | 2025 | 56 | 0.060 |
Why?
| | Viral Proteins | 1 | 2025 | 161 | 0.050 |
Why?
| | Plasmodium falciparum | 1 | 2022 | 19 | 0.050 |
Why?
| | Lasers, Semiconductor | 1 | 2022 | 10 | 0.050 |
Why?
| | Early Detection of Cancer | 1 | 2022 | 163 | 0.040 |
Why?
| | Genetic Predisposition to Disease | 2 | 2011 | 507 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 579 | 0.030 |
Why?
| | Schizonts | 1 | 2016 | 3 | 0.030 |
Why?
| | Ear | 1 | 2016 | 17 | 0.030 |
Why?
| | Host-Parasite Interactions | 1 | 2016 | 16 | 0.030 |
Why?
| | Computers, Handheld | 1 | 2016 | 25 | 0.030 |
Why?
| | Genes, Reporter | 1 | 2016 | 88 | 0.030 |
Why?
| | Green Fluorescent Proteins | 1 | 2016 | 91 | 0.030 |
Why?
| | Early Diagnosis | 1 | 2016 | 86 | 0.030 |
Why?
| | Lasers | 1 | 2016 | 107 | 0.030 |
Why?
| | Chick Embryo | 1 | 2014 | 83 | 0.030 |
Why?
| | Cytoprotection | 1 | 2014 | 34 | 0.030 |
Why?
| | Radiation Chimera | 1 | 2011 | 3 | 0.020 |
Why?
| | Mice, Inbred CBA | 1 | 2011 | 35 | 0.020 |
Why?
| | Mice, 129 Strain | 1 | 2011 | 37 | 0.020 |
Why?
| | Concanavalin A | 1 | 2011 | 15 | 0.020 |
Why?
| | Mitogens | 1 | 2011 | 10 | 0.020 |
Why?
| | CTLA-4 Antigen | 1 | 2011 | 23 | 0.020 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2011 | 54 | 0.020 |
Why?
| | Receptors, Tumor Necrosis Factor, Member 25 | 1 | 2010 | 1 | 0.020 |
Why?
| | Bone Marrow Transplantation | 1 | 2011 | 112 | 0.020 |
Why?
| | Plasmodium berghei | 1 | 2010 | 4 | 0.020 |
Why?
| | Lymphocyte Count | 1 | 2010 | 20 | 0.020 |
Why?
| | Graft Rejection | 1 | 2011 | 168 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2011 | 379 | 0.020 |
Why?
| | Transforming Growth Factor beta | 1 | 2010 | 136 | 0.020 |
Why?
| | Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2009 | 4 | 0.020 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2010 | 123 | 0.020 |
Why?
| | Encephalomyelitis, Autoimmune, Experimental | 1 | 2009 | 20 | 0.020 |
Why?
| | Kidney Transplantation | 1 | 2011 | 174 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2009 | 110 | 0.020 |
Why?
| | Acute Disease | 1 | 2010 | 367 | 0.020 |
Why?
| | Time Factors | 1 | 2014 | 2883 | 0.020 |
Why?
| | STAT4 Transcription Factor | 1 | 2007 | 3 | 0.020 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2007 | 5 | 0.020 |
Why?
| | Ovalbumin | 1 | 2007 | 18 | 0.020 |
Why?
| | STAT5 Transcription Factor | 1 | 2007 | 10 | 0.020 |
Why?
| | STAT6 Transcription Factor | 1 | 2007 | 8 | 0.020 |
Why?
| | Th2 Cells | 1 | 2007 | 22 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2010 | 1352 | 0.020 |
Why?
| | Feedback | 1 | 2007 | 52 | 0.020 |
Why?
| | Immunization | 1 | 2007 | 63 | 0.020 |
Why?
| | Liver | 1 | 2010 | 1108 | 0.010 |
Why?
|
|
Stumhofer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|